
Formosa Laboratories Inc
TWSE:4746

Formosa Laboratories Inc
Retained Earnings
Formosa Laboratories Inc
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Formosa Laboratories Inc
TWSE:4746
|
Retained Earnings
NT$2.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Retained Earnings
NT$2.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Retained Earnings
NT$1.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Retained Earnings
NT$2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Retained Earnings
NT$12.7B
|
CAGR 3-Years
95%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Retained Earnings
NT$3.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

See Also
What is Formosa Laboratories Inc's Retained Earnings?
Retained Earnings
2.7B
TWD
Based on the financial report for Dec 31, 2024, Formosa Laboratories Inc's Retained Earnings amounts to 2.7B TWD.
What is Formosa Laboratories Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
21%
Over the last year, the Retained Earnings growth was -3%. The average annual Retained Earnings growth rates for Formosa Laboratories Inc have been 1% over the past three years , 22% over the past five years , and 21% over the past ten years .